HNRNPA3P7

Across TCGA pan-cancer cohorts, HNRNPA3P7 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated HNRNPA3P7 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher HNRNPA3P7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HNRNPA3P7 expression acts as an unfavorable survival marker, although some lineages such as SKCM and CESC show a favorable association.

STAD, SKCM, and CESC are the cancer types where HNRNPA3P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	IV	0.126	0.742	.004	113	view →
SKCM	OS	Median	All	0.844	0.730	<.001	67	view →
CESC	OS	Median	II,III,IV	0.838	0.649	.009	26	view →
BLCA	OS	Median	All	0.733	0.461	.001	25	view →
DLBC	OS	Tertile	All	0.741	1.000	.007	17	view →
READ	DFS	Quartile	All	0.954	0.259	<.001	15	view →
GBM	DFS	Quartile	All	0.557	0.242	.002	12	view →
LIHC	OS	Quartile	III,IV	0.453	0.818	.017	11	view →
BRCA	DFS	Tertile	IV	0.447	0.752	.029	10	view →
PCPG	DFS	Median	All	0.953	0.723	.017	9	view →
CHOL	DFS	Tertile	III,IV	0.133	0.779	.038	6	view →
ESCA	DFS	Quartile	III,IV	0.474	0.238	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

HNRNPA3P7–STAD (DFS)

Open the STAD breakdown →